EMERYVILLE, Calif. (AP) _ Adamas Pharmaceuticals Inc. (ADMS) on Thursday reported a loss of $29.7 million in its first quarter.
On a per-share basis, the Emeryville, California-based company said it had a loss of $1.08.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.13 per share.
The drugmaker posted revenue of $11.7 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $12.8 million.
Adamas shares have declined 31% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.93, a drop of 81% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMS at https://www.zacks.com/ap/ADMS